Japanese CTO PCI Expert Registry

Launched by KURASHIKI CENTRAL HOSPITAL · Jun 26, 2013

Keywords

ClinConnect Summary

The Japanese CTO PCI Expert Registry is a clinical trial aimed at improving treatment strategies for patients with chronic total occlusion (CTO) of the coronary arteries. CTO occurs when a coronary artery is completely blocked for a long time, which can lead to serious heart issues. This study will collect information from patients who are treated using a procedure called percutaneous coronary intervention (PCI), which is a minimally invasive way to open blocked arteries. The goal is to gather insights from experienced Japanese doctors to develop a better understanding of how to treat these complex cases effectively.

To participate in this trial, patients must be eligible for PCI and have specific types of blocked arteries, including those that have been completely blocked for more than three months. The study is open to adults of all genders. Participants can expect to receive standard care during their treatment, and their progress will be monitored as part of the registry. This research will help set best practices for treating CTO in the future, ultimately aiming to improve outcomes for patients facing this challenging condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients eligible for PCI
• Patients who underwent PCI for CTO lesions that contain the following:
• • 1. Thrombolysis in myocardial infarction trial (TIMI) 0
• • 2. The occlusive period more than 3 months or unknown
• • 3. The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft
• Exclusion Criteria:
• • Patients ineligible for PCI judged in clinical practice